Tandem Mobi® Region 2 Downloads & RevenueTandem Mobi® Region 2 · App Store
Tandem Mobi® Region 2 is #190 in Medical Free in Italy and charting in 1 of 30 countries we track.
Updated 11 Nov 2026 · rankings refresh through the day
DeveloperTandem Diabetes Care Inc.
CategoryMedical
PriceFree
Released
Rating★ 4.0 (1)
Version3.6.2
Age rating4+
First seen by us
25 Sep 2026
25 Sep 2026Tandem Mobi® Region 2 update history & changes
Last change · 4 events since 18 Aug 2026Full timeline ↓Full timeline · 4 events
- 📈Tandem Mobi® Region 2 charting in a new countryUnited Kingdom
- 🆕Tandem Mobi® Region 2 first spotted by AppInsider#100 in Top Free · Medical · Italy
- 📦Tandem Mobi® Region 2 version 3.6.2No release notes
- 🆕Tandem Mobi® Region 2 released on the App Store
Collected from the stores by AppInsider since we first spotted the app. Dates are when we saw each change.
Rating
4.0 ★
1 ratings
Measured
Best rank now
#190
Medical FreeMeasured
Tandem Mobi® Region 2 on the App Store
App details
App ID
6758737652
Publisher
Tandem Diabetes Care, Inc.
On the store since
Aug 2026
Under a year
Minimum OS
iOS 18.0+
iPhone XS and later
Devices
iPhone · iPad
Content rating
4+
Languages
12
CS DA NL EN FI FR DE IT NB PT ES SV
Size
164 MB
Also listed in
Health & Fitness
Where Tandem Mobi® Region 2's downloads come from Modelled
Last 30 days: organic search, browsing the store, features and paid ads.
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Italy | MedicalFree | #190 |
Apps near Tandem Mobi® Region 2 on the chart
Medical Free, around #190.
Ratings
App Store, worldwide.
Rating
4.0 ★
1 ratings
Measured
Ratings
1
Measured
Review momentum
ⓘ How we measure thisNew ratings a week
under 1
4-week average
Lifetime rating
4.0★
recent stars not readable yet: new ratings are a tiny share of the total
Review momentum
20/100
faster than 0% of Medical apps
Review momentum (0-100) blends how fast the app collects ratings compared with other apps in its category (60%), whether that pace is speeding up (25%) and what recent raters give it (15%; recent stars well below lifetime pull it down). Ratings counts are read daily. A jump usually means a launch, a feature, ads or a new review prompt.
About Tandem Mobi® Region 2
Tandem Mobi is the world’s smallest, durable automated insulin delivery system.1 Impressively small and offering next-level convenience and discretion, Tandem Mobi is controllable with a compatible, personal iPhone.*
Use of the Tandem Mobi mobile app requires a prescription. Always consult a healthcare professional for information about how to manage diabetes.
Features
* Mobile Control: The Tandem Mobi system is controllable from a compatible, personal iPhone, offering discreet and convenient access to therapy data and pump functions*
* Advanced Therapy Visualization: View a 24-hour graphical representation of glucose readings (CGM and BGM), basal and bolus events, insulin on board, carbohydrate intake, suspensions, and other therapy-related data
* Pump Status Monitoring: Real-time visibility into pump battery level, available insulin, active Personal Profile, CGM sensor and transmitter status, and more
* Customizable User Experience: Personal Profiles and activity settings allow users to tailor therapy to their lifestyle, with enhanced personalization features
* AutoBolus: The only system with AutoBolus to help with missed meal boluses and preventing hyperglycemia†
* Seamless Data Sync: Wireless data uploads to the Tandem Source platform to ensure therapy data is securely backed up and accessible‡
ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. The electronic instructions for use for the Tandem Mobi mobile app (Basic UDI-DI: 00389152690940) can be accessed through the Tandem Mobi user guide, available here: https://www.tandemdiabetes.com/support/resources/documents. Upon request, a printed copy of the user guide can be provided within seven days at no additional cost.
If the language set on your smartphone is supported by the mobile app, then the mobile app will display in that language. If the language set on your smartphone is not supported by the mobile app, then the mobile app will display in English.
*The mobile app requires a compatible smartphone model and operating system (sold separately). †If glucose values are predicted to be above 180 mg/dL (or 10.0 mmol/L), Control-IQ+ technology calculates an AutoBolus using the Personal Profile settings and a target of 110 mg/dL (or 6.1 mmol/L) and delivers 60% of that value. ‡Uploads to the Tandem Source platform do not take place in real time and should not be relied upon by healthcare providers, pump users, or caregivers for remote patient monitoring. Standard carrier data rates may apply. Smartphone sold separately.
Reference
1. As of Dec., 2025. Data on file, Tandem Diabetes Care.
Use of the Tandem Mobi mobile app requires a prescription. Always consult a healthcare professional for information about how to manage diabetes.
Features
* Mobile Control: The Tandem Mobi system is controllable from a compatible, personal iPhone, offering discreet and convenient access to therapy data and pump functions*
* Advanced Therapy Visualization: View a 24-hour graphical representation of glucose readings (CGM and BGM), basal and bolus events, insulin on board, carbohydrate intake, suspensions, and other therapy-related data
* Pump Status Monitoring: Real-time visibility into pump battery level, available insulin, active Personal Profile, CGM sensor and transmitter status, and more
* Customizable User Experience: Personal Profiles and activity settings allow users to tailor therapy to their lifestyle, with enhanced personalization features
* AutoBolus: The only system with AutoBolus to help with missed meal boluses and preventing hyperglycemia†
* Seamless Data Sync: Wireless data uploads to the Tandem Source platform to ensure therapy data is securely backed up and accessible‡
ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. The electronic instructions for use for the Tandem Mobi mobile app (Basic UDI-DI: 00389152690940) can be accessed through the Tandem Mobi user guide, available here: https://www.tandemdiabetes.com/support/resources/documents. Upon request, a printed copy of the user guide can be provided within seven days at no additional cost.
If the language set on your smartphone is supported by the mobile app, then the mobile app will display in that language. If the language set on your smartphone is not supported by the mobile app, then the mobile app will display in English.
*The mobile app requires a compatible smartphone model and operating system (sold separately). †If glucose values are predicted to be above 180 mg/dL (or 10.0 mmol/L), Control-IQ+ technology calculates an AutoBolus using the Personal Profile settings and a target of 110 mg/dL (or 6.1 mmol/L) and delivers 60% of that value. ‡Uploads to the Tandem Source platform do not take place in real time and should not be relied upon by healthcare providers, pump users, or caregivers for remote patient monitoring. Standard carrier data rates may apply. Smartphone sold separately.
Reference
1. As of Dec., 2025. Data on file, Tandem Diabetes Care.
Latest updates
3.6.2
